World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Reimagining stem cell cultivation

Reimagining stem cell cultivation

by admin | Jan 17, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Susan Buckles MayoClinic.com (link to article) Mayo Clinic has discovered how to microencapsulate pluripotent stem cells to potentially make them easier and less expensive to process and more effective for fighting disease. This research by Alexander Revzin, Ph.D.,...
Stem Cells or PRP for Equine Tendon and Ligament Injuries?

Stem Cells or PRP for Equine Tendon and Ligament Injuries?

by admin | Jan 15, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Alexandra Beckstett, The Horse Managing Editor, TheHorse.com (link to article) Indications for their use and how veterinarians choose between the two therapies. In recent years, there’s been tremendous interest in using regenerative therapies (or, more accurately,...
First-ever pig-to-human heart transplant offers hope for thousands in need of organs

First-ever pig-to-human heart transplant offers hope for thousands in need of organs

by admin | Jan 14, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Karen Weintraub – January 10, 2022 – APNews.com  (link to article) A Maryland man has lived for three days with a pig heart beating inside his chest. The surgery, at the University of Maryland Medical Center, marks the first time a gene-edited pig has...
Pfizer Makes Foray Into CRISPR, Inking .35 Billion Deal With Beam Therapeutics

Pfizer Makes Foray Into CRISPR, Inking $1.35 Billion Deal With Beam Therapeutics

by admin | Jan 12, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By: ALLISON GATLIN – Investors.com – 01/10/2022 (link to article) Pfizer (PFE) is entering the CRISPR space through a $1.35 billion deal with Beam Therapeutics (BEAM), the companies announced Monday. But Beam stock fell on the deal. Beam is using CRISPR...
Auto Draft

For everything there is a season

by admin | Dec 24, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

As 2021 draws to a close, we celebrate the first decade of STEM CELLS Translational Medicine (SCTM) with gratitude to our devoted editors, reviewers, authors, and of course, our global loyal readership … all of you are a vital part of this first decade’s...
Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

by admin | Dec 8, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Margarida Maia, PhD Repeat injections of mesenchymal stem cells (MSCs) into the spinal canal were safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), and showed potential to significantly slow the rate of disease progression, a small Phase...
Page 158 of 206« First«...102030...156157158159160...170180190...»Last »

Recent Posts

  • Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis
  • How Our Own Cells Could Implant The Next Generation Of Nonsurgical Brain Microchips
  • Melanoma cancer cells secrete extracellular vesicles to paralyze immune cells
  • Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy
  • Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
  • Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow